Serum lipid profiles and cholesterol-lowering medication use in relation to subsequent risk of colorectal cancer in the UK Biobank cohort.
Fangcheng YuanWanqing WenGuochong JiaJirong LongChristina E BaileyQuan LongPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Our findings call for careful consideration of cholesterol-lowering medication use in future studies of blood lipid-CRC associations.